Literature DB >> 21439654

Immunological changes in canine peripheral blood leukocytes triggered by immunization with first or second generation vaccines against canine visceral leishmaniasis.

Márcio Sobreira Silva Araújo1, Renata Aline de Andrade, Renato Sathler-Avelar, Camila Paula Magalhães, Andréa Teixeira Carvalho, Mariléia Chaves Andrade, Sabrina Sidney Campolina, Maria Norma Mello, Leonardo Rocha Vianna, Wilson Mayrink, Alexandre Barbosa Reis, Luiz Cosme Cotta Malaquias, Luciana Morais Rocha, Olindo Assis Martins-Filho.   

Abstract

In this study, we summarized the major phenotypic/functional aspects of circulating leukocytes following canine immunization with Leishvaccine and Leishmune®. Our findings showed that Leishvaccine triggered early changes in the innate immunity (neutrophils and eosinophils) with late alterations on monocytes. Conversely, Leishmune(®) induced early phenotypic changes in both, neutrophils and monocytes. Moreover, Leishvaccine triggered mixed activation-related phenotypic changes on T-cells (CD4+ and CD8+ and B-lymphocytes, whereas Leishmune(®) promoted a selective response, mainly associated with CD8+ T-cell activation. Mixed cytokine profile (IFN-γ/IL-4) was observed in Leishvaccine immunized dogs whereas a selective pro-inflammatory pattern (IFN-γ/NO) was induced by Leishmune® vaccination. The distinct immunological profile triggered by Leishvaccine and Leishmune® may be a direct consequence of the distinct biochemical composition of these immunobiological, i.e. complex versus purified Leishmania antigen along with Bacillus Calmette-Guérin (BCG) versus saponin adjuvant. Both immunobiologicals are able to activate phagocytes and CD8+ T-cells and therefore could be considered as a putative vaccines against canine visceral leishmaniasis (CVL).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439654     DOI: 10.1016/j.vetimm.2011.02.007

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  12 in total

Review 1.  One Health: the global challenge of epidemic and endemic leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa; Michael J Day
Journal:  Parasit Vectors       Date:  2011-10-10       Impact factor: 3.876

2.  One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.

Authors:  Christiane Costa-Pereira; Marcela L Moreira; Rodrigo P Soares; Bruno H Marteleto; Vitor M Ribeiro; Michelle H França-Dias; Ludmila M Cardoso; Kelvinson F Viana; Rodolfo C Giunchetti; Olindo A Martins-Filho; Márcio S S Araújo
Journal:  BMC Vet Res       Date:  2015-04-11       Impact factor: 2.741

3.  LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.

Authors:  Rodrigo Dian de Oliveira Aguiar-Soares; Bruno Mendes Roatt; Henrique Gama Ker; Nádia das Dores Moreira; Fernando Augusto Siqueira Mathias; Jamille Mirelle de Oliveira Cardoso; Nelder Figueiredo Gontijo; Oscar Bruna-Romero; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Rodrigo Corrêa-Oliveira; Rodolfo Cordeiro Giunchetti; Alexandre Barbosa Reis
Journal:  Parasit Vectors       Date:  2014-02-07       Impact factor: 3.876

Review 4.  Vaccines for canine leishmaniasis.

Authors:  Faeze Foroughi-Parvar; Gholamreza Hatam
Journal:  Adv Prev Med       Date:  2014-12-31

5.  An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.

Authors:  Eva Iniguez; Nathaniel S Schocker; Krishanthi Subramaniam; Susana Portillo; Alba L Montoya; Waleed S Al-Salem; Caresse L Torres; Felipe Rodriguez; Otacilio C Moreira; Alvaro Acosta-Serrano; Katja Michael; Igor C Almeida; Rosa A Maldonado
Journal:  PLoS Negl Trop Dis       Date:  2017-10-25

6.  Setting the proportion of CD4+ and CD8+ T-cells co-cultured with canine macrophages infected with Leishmania chagasi.

Authors:  Kelvinson Fernandes Viana; Rodrigo Dian Oliveira Aguiar-Soares; Henrique Gama Ker; Lucilene Aparecida Resende; Elaine Maria Souza-Fagundes; Walderez Ornelas Dutra; Ricardo Toshio Fujiwara; Denise da Silveira-Lemos; Rita de Cássia Oliveira Sant'Ana; Amanda Brito Wardini; Márcio Sobreira Silva Araújo; Olindo Assis Martins-Filho; Alexandre Barbosa Reis; Rodolfo Cordeiro Giunchetti
Journal:  Vet Parasitol       Date:  2015-06-03       Impact factor: 2.738

7.  Vaccines for canine leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

8.  Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection.

Authors:  Dirlei Nico; Daniele Crespo Gomes; Iam Palatnik-de-Sousa; Alexandre Morrot; Marcos Palatnik; Clarisa Beatriz Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2014-06-11       Impact factor: 7.561

9.  Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).

Authors:  Kelvinson Fernandes Viana; Jacqueline Araújo Fiuza; Sreenivas Gannavaram; Ranadhir Dey; Angamuthu Selvapandiyan; Daniella Castanheira Bartholomeu; Denise da Silveira-Lemos; Lilian Lacerda Bueno; Walderez Ornelas Dutra; Ricardo Toshio Fujiwara; Hira L Nakhasi; Rodolfo Cordeiro Giunchetti
Journal:  Parasit Vectors       Date:  2016-04-30       Impact factor: 3.876

10.  Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.

Authors:  Ludmila Zanandreis de Mendonça; Lucilene Aparecida Resende; Mariana Ferreira Lanna; Rodrigo Dian de Oliveira Aguiar-Soares; Bruno Mendes Roatt; Renata Alves de Oliveira E Castro; Maurício Azevedo Batista; Denise Silveira-Lemos; Juliana de Assis Silva Gomes; Ricardo Toshio Fujiwara; Simone Aparecida Rezende; Olindo Assis Martins-Filho; Rodrigo Corrêa-Oliveira; Walderez Ornelas Dutra; Alexandre Barbosa Reis; Rodolfo Cordeiro Giunchetti
Journal:  Parasit Vectors       Date:  2016-08-30       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.